Personalized Assessments for Childhood OCD
Trial Summary
What is the purpose of this trial?
The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD
Will I have to stop taking my current medications?
You can participate if you are not taking any medications or if you have been on a stable dose of your current medication for at least 8 weeks before joining the study.
What data supports the effectiveness of the treatment Exposure with Response Prevention (ERP) for childhood OCD?
Research shows that ERP, a type of therapy where children face their fears without performing their usual rituals, is effective in reducing OCD symptoms in children. Studies highlight the importance of family involvement and suggest that combining ERP with parent management training can enhance its effectiveness, especially in children with additional disruptive behaviors.12345
Is Exposure with Response Prevention (ERP) safe for treating OCD in children?
How is the treatment Exposure with Response Prevention (ERP) unique for childhood OCD?
Exposure with Response Prevention (ERP) is unique for childhood OCD because it involves facing fears (exposure) without performing compulsive behaviors (response prevention), and it often includes family involvement to reduce family accommodation of OCD behaviors, which is not typically emphasized in other treatments.23489
Research Team
Joseph F. McGuire, PhD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for children and teens aged 8-17 with a primary diagnosis of OCD, as confirmed by an interview. They should have moderate OCD severity and be either medication-free or on a stable dose for at least 8 weeks. Participants must speak English but can't join if they're already in psychotherapy for OCD, have certain other mental health conditions, or are at immediate risk of harming themselves.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 12 sessions of exposure with response prevention (ERP) guided by either standard practice or personalized assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Exposure with Response Prevention
Exposure with Response Prevention is already approved in United States, European Union, Canada for the following indications:
- Obsessive-Compulsive Disorder (OCD)
- Obsessive-Compulsive Disorder (OCD)
- Obsessive-Compulsive Disorder (OCD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor